APM - Aptorum Group Ltd
0.97
-0.030 -3.093%
Share volume: 22,941
Last Updated: 04-25-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.10%
PREVIOUS CLOSE
CHG
CHG%
$1.00
-0.03
-0.03%
Fundamental analysis
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Performance
5 Days
6.24%
1 Month
10.28%
3 Months
-5.83%
6 Months
-5.83%
1 Year
-5.83%
2 Year
-5.83%
Key data
Stock price
$0.97
DAY RANGE
$0.94 - $1.00
52 WEEK RANGE
$0.69 - $1.34
52 WEEK CHANGE
-$5.83
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
Company detail
CEO: Darren Lui
Region: US
Website: www.aptorumgroup.com
Employees: 30
IPO year: 2018
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: www.aptorumgroup.com
Employees: 30
IPO year: 2018
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Aptorum Group Limited engages in the discovery, development, and commercialization of therapeutic products. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas.
Recent news
